Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A novel xenograft model of cutaneous T‐cell lymphoma
Thorbjørn Krejsgaard, Katharina Kopp, Elisabeth Ralfkiær, et al.
Experimental Dermatology (2010) Vol. 19, Iss. 12, pp. 1096-1102
Closed Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

Broadly Neutralizing Antibodies and Viral Inducers Decrease Rebound from HIV-1 Latent Reservoirs in Humanized Mice
Ariel Halper-Stromberg, Ching-Lan Lu, Florian Klein, et al.
Cell (2014) Vol. 158, Iss. 5, pp. 989-999
Open Access | Times Cited: 356
Diagnostic microRNA profiling in cutaneous T-cell lymphoma (CTCL)
Ulrik Ralfkiær, Peter Hagedorn, Nannie Bangsgaard, et al.
Blood (2011) Vol. 118, Iss. 22, pp. 5891-5900
Open Access | Times Cited: 231
Overview of the Use of Murine Models in Leukemia and Lymphoma Research
Rebecca Kohnken, Pierluigi Porcu, Anjali Mishra
Frontiers in Oncology (2017) Vol. 7
Open Access | Times Cited: 87
Role of Dysregulated Cytokine Signaling and Bacterial Triggers in the Pathogenesis of Cutaneous T-Cell Lymphoma
Melania H. Fanok, Amy Sun, Laura K. Fogli, et al.
Journal of Investigative Dermatology (2017) Vol. 138, Iss. 5, pp. 1116-1125
Open Access | Times Cited: 85
Thrombospondin-1 promotes tumor progression in cutaneous T-cell lymphoma via CD47
Hiroaki Kamijo, Tomomitsu Miyagaki, Naomi Shishido, et al.
Leukemia (2019) Vol. 34, Iss. 3, pp. 845-856
Closed Access | Times Cited: 55
Evidence of an oncogenic role of aberrant TOX activation in cutaneous T-cell lymphoma
Yuanshen Huang, Mingwan Su, Xiaoyan Jiang, et al.
Blood (2014) Vol. 125, Iss. 9, pp. 1435-1443
Open Access | Times Cited: 65
Spleen cancer: Current status of preclinical research
Gaurav Tiwari, Surender Beniwal, Shashi Ravi Suman Rudrangi, et al.
Elsevier eBooks (2025), pp. 45-68
Closed Access
cMyc/miR-125b-5p Signalling Determines Sensitivity to Bortezomib in Preclinical Model of Cutaneous T-Cell Lymphomas
Valentina Manfé, Edyta Biskup, Ayalah Willumsgaard, et al.
PLoS ONE (2013) Vol. 8, Iss. 3, pp. e59390-e59390
Open Access | Times Cited: 49
Aberrant CD137 ligand expression induced by GATA6 overexpression promotes tumor progression in cutaneous T-cell lymphoma
Hiroaki Kamijo, Tomomitsu Miyagaki, Naomi Shishido, et al.
Blood (2018) Vol. 132, Iss. 18, pp. 1922-1935
Open Access | Times Cited: 39
B-lymphoid tyrosine kinase (Blk) is an oncogene and a potential target for therapy with dasatinib in cutaneous T-cell lymphoma (CTCL)
David L. Petersen, Thorbjørn Krejsgaard, Jens Berthelsen, et al.
Leukemia (2014) Vol. 28, Iss. 10, pp. 2109-2112
Open Access | Times Cited: 41
Malignant T Cells Secrete Galectins and Induce Epidermal Hyperproliferation and Disorganized Stratification in a Skin Model of Cutaneous T-Cell Lymphoma
Christenze Thode, Anders Woetmann, Hans H. Wandall, et al.
Journal of Investigative Dermatology (2014) Vol. 135, Iss. 1, pp. 238-246
Open Access | Times Cited: 39
Alkylphosphocholines and curcumin induce programmed cell death in cutaneous T-cell lymphoma cell lines
Deyan Y. Yosifov, Kaloyan Kaloyanov, Margarita Guenova, et al.
Leukemia Research (2013) Vol. 38, Iss. 1, pp. 49-56
Closed Access | Times Cited: 33
Malignant T cells express lymphotoxin α and drive endothelial activation in cutaneous T cell lymphoma
Britt Lauenborg, Louise Dahl Christensen, Ulrik Ralfkiær, et al.
Oncotarget (2015) Vol. 6, Iss. 17, pp. 15235-15249
Open Access | Times Cited: 30
Sézary syndrome: old enigmas, new targets
Jan P. Nicolay, Moritz Felcht, Kai Schledzewski, et al.
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2016) Vol. 14, Iss. 3, pp. 256-264
Open Access | Times Cited: 28
Current and Emerging Therapeutics for Cutaneous T-Cell Lymphoma: Histone Deacetylase Inhibitors
Annabelle L. Rodd, Katherine Ververis, Tom C. Karagiannis
Lymphoma (2012) Vol. 2012, pp. 1-10
Open Access | Times Cited: 28
Oncogenic role of microRNA‐155 in mycosis fungoides: an in vitro and xenograft mouse model study
Lilach Moyal, Shiran Yehezkel, B. Gorovitz, et al.
British Journal of Dermatology (2017) Vol. 177, Iss. 3, pp. 791-800
Closed Access | Times Cited: 28
Vascular endothelial growth factor receptor-3 expression in mycosis fungoides
Ida Holst Pedersen, Andreas Willerslev-Olsen, Claudia S. Vetter‐Kauczok, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2012) Vol. 54, Iss. 4, pp. 819-826
Closed Access | Times Cited: 25
Xenograft and cell culture models of Sézary syndrome reveal cell of origin diversity and subclonal heterogeneity
Sandrine Poglio, Martina Prochazkova‐Carlotti, Floriane Cherrier, et al.
Leukemia (2020) Vol. 35, Iss. 6, pp. 1696-1709
Open Access | Times Cited: 20
Cutaneous T-Cell Lymphoma PDX Drug Screening Platform Identifies Cooperation between Inhibitions of PI3Kα/δ and HDAC
Chi-Heng Wu, Chen‐Yen Yang, Linlin Wang, et al.
Journal of Investigative Dermatology (2020) Vol. 141, Iss. 2, pp. 364-373
Open Access | Times Cited: 18
CD147-Cyclophilin a Interactions Promote Proliferation and Survival of Cutaneous T-Cell Lymphoma
Minami Sakamoto, Tomomitsu Miyagaki, Hiroaki Kamijo, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 15, pp. 7889-7889
Open Access | Times Cited: 17
PEG10 amplification at 7q21.3 potentiates large-cell transformation in cutaneous T-cell lymphoma
Fengjie Liu, Yumei Gao, Bufang Xu, et al.
Blood (2021) Vol. 139, Iss. 4, pp. 554-571
Open Access | Times Cited: 16
Understanding Cell Lines, Patient-Derived Xenograft and Genetically Engineered Mouse Models Used to Study Cutaneous T-Cell Lymphoma
Raman Preet Kaur Gill, Jennifer Gantchev, Amelia Martínez Villarreal, et al.
Cells (2022) Vol. 11, Iss. 4, pp. 593-593
Open Access | Times Cited: 11
Possible therapeutic applicability of galectin-9 in cutaneous T-cell lymphoma
Rina Nakajima, Tomomitsu Miyagaki, Hiroaki Kamijo, et al.
Journal of Dermatological Science (2019) Vol. 96, Iss. 3, pp. 134-142
Open Access | Times Cited: 18
A novel mouse model for Sézary Syndrome using xenotransplantation of Sézary cells into immunodeficient RAG2−/− γc−/− mice
Leslie van der Fits, Heggert Rebel, Jacoba J. Out‐Luiting, et al.
Experimental Dermatology (2012) Vol. 21, Iss. 9, pp. 706-709
Closed Access | Times Cited: 19
Models for mature T-cell lymphomas—A critical appraisal of experimental systems and their contribution to current T-cell tumorigenic concepts
Kathrin Warner, Giuliano Crispatzu, Nabil Al-Ghaili, et al.
Critical Reviews in Oncology/Hematology (2013) Vol. 88, Iss. 3, pp. 680-695
Closed Access | Times Cited: 17
Page 1 - Next Page

Scroll to top